Scientists hunt for biomarkers to predict brain vessel disease

NCT ID NCT06960538

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This completed study looked at 200 people with cerebral amyloid angiopathy (CAA), a condition where protein builds up in brain blood vessels, raising the risk of bleeding and cognitive decline. Researchers collected clinical data, brain scans, and samples of spinal fluid and blood to find markers that could help predict how the disease will progress. The goal is to improve early diagnosis and personalize treatment, but this is an observational study, not a test of a new drug.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this study could point toward better ways to diagnose and predict the progression of cerebral amyloid angiopathy, potentially leading to personalized treatment targets.
What could go wrong
This is an observational study, not a treatment trial, so it will not directly provide a new therapy. The findings may not lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CAA - CEREBRAL AMYLOID ANGIOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral amyloid angiopathy Cerebral Amyloid Angiopathy, Familial

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fondazione IRCCS Istituto Neurologico Carlo Besta

    Milan, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.